Keywords: Poly(sialic acid); Liposomes; Peripheral blood neutrophils; Tumour-targeting; Drug delivery system; PSA-p-ODA; poly(sialic acid)-p-octadecylamine conjugate; PBNs; peripheral blood neutrophils; TANs; tumour-associated neutrophils; DiR-CL; DiR-labeled unmod